Merck & Co Inc

NYSE:MRK   3:04:07 PM EDT
79.91
+1.62 (+2.07%)
Products, Regulatory

Alx Oncology Holdings Inc Says Entered Into A Clinical Trial Collaboration With Merck

Published: 09/22/2020 11:20 GMT
Merck & Co Inc (MRK) - Alx Oncology Holdings Inc - Entered Into a Clinical Trial Collaboration With Merck.
Alx Oncology - Collaboration With Merck to Evaluate Combination of Alx148 & Keytruda for Treatment of Patients With Head & Neck Squamous Cell Carcinoma.
Alx Oncology Holdings - Under Terms of Agreement, Co Will Conduct a Phase 2 Program Comprising Two Separate Phase 2 Studies.